NCT01307410 A Comprehensive Longitudinal Cohort Study in Type 2 Diabetes With High Risk of Cardiovascular Diseases in China Status UNKNOWN Phase N/A
NCT01306266 Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military Troops Status WITHDRAWN Phase NA
NCT01304498 Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009) Status COMPLETED Phase PHASE3
NCT01304264 Intraocular Pressure, Blood Pressure, Ocular Perfusion and Blood Flow Fluctuations in Glaucoma Patients Status COMPLETED Phase N/A
NCT01302691 MK-0954E Study in Participants With Hypertension (MK-0954E-357) Status COMPLETED Phase PHASE3
NCT01300455 Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036) Status COMPLETED Phase PHASE1
NCT01299714 Community Awareness, Resources and Education (CARE II): Project 3 Status COMPLETED Phase N/A
NCT01299376 MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356) Status COMPLETED Phase PHASE3
NCT01298193 Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer. Status COMPLETED Phase PHASE4
NCT01296659 Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma Status WITHDRAWN Phase PHASE1
NCT01296529 Study on Immunopathogenesis in HIV and Hepatitis C Coinfection Status COMPLETED Phase N/A
NCT01296412 Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403) Status COMPLETED Phase PHASE3
NCT01296165 International Travel and the Spread of Extended-spectrum Beta-lactamase-producing Escherichia Coli Status COMPLETED Phase N/A
NCT01295827 Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) Status COMPLETED Phase PHASE1
NCT01295632 Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049) Status COMPLETED Phase PHASE1
NCT01294800 A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402) Status COMPLETED Phase PHASE2
NCT01294735 Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1) Status COMPLETED Phase PHASE1
NCT01294709 A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014) Status COMPLETED Phase PHASE1
NCT01294683 A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118) Status TERMINATED Phase PHASE3